Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Medical and Pediatric Oncology|January 1, 1978
Mitomycin-C alone and in combination with infused 5-fluorouracil to the treatment of disseminated gastrointestinal carcinomasT R Buroker, P N Kim, L H Baker, et al.
Cancer Treatment Reports|February 1, 1982
Clinical trial of chlorozotocin, DTIC, and dactinomycin in metastatic malignant melanomaM K Samson, L H Baker, G Cummings, et al.
The Journal of Urology|March 1, 1981
The relationship of herpesvirus to carcinoma of the prostateL H Baker, W K Mebust, T D Chin, et al.
Cancer|September 15, 1990
A common cytogenetic abnormality and DNA content alterations in dedifferentiated chondrosarcomaM M Zalupski, J F Ensley, J Ryan, et al.
Medical Education|September 1, 1978
Measuring clinical competence of medical studentsF F Holmes, L H Baker, E C Torian, et al.
Cancer Research|August 1, 1988
Acodazole hydrochloride: phase I trial, pharmacokinetics, and evaluation of cardiotoxicity in dogsR Pazdur, G G Chabot, C A Campbell, et al.
American Journal of Clinical Oncology|February 1, 1983
Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-(piperidyl)-1 nitrosourea (PCNU)(NSC-95466) in patients with advanced carcinoma of the lungV Ratanatharathorn, M K Samson, C D Haas, et al.
Cancer|March 4, 2000
Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group StudyS K Williamson, D Lew, G J Miller, et al.
American Journal of Clinical Oncology|August 1, 1993
Phase II trial of merbarone in pancreatic carcinoma. A Southwest Oncology Group studyE H Kraut, T Fleming, J S Macdonald, et al.
Cancer|January 15, 1993
Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group studyR M Bukowski, T R Fleming, J S Macdonald, et al.
Pageof 13